Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease-Reference-Cited by-同舟云学术

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease

Published:2002-06 Issue:6 Volume:97 Page:1458-1462
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

Esters N.,Vermeire S.,Joossens S.,Noman M.,Louis E.,Belaiche J.,Vos M.,Gossum A.,Pescatore P.,Fiasse R.,Pelckmans P.,Reynaert H.,Poulain D.,Bossuyt X.,Rutgeerts P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference26 articles.

1. A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

2. Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

3. Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

4. Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis

5. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease.

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease;Gastroenterology;2024-07

2. Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond;Diagnostics;2024-06-28

3. The Role of Serological Markers in the Prediction of Disease Course and Response to Therapy in Inflammatory Bowel Disease;Cureus;2023-11-07

4. Antibody signatures in inflammatory bowel disease: current developments and future applications;Trends in Molecular Medicine;2022-08

5. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases;Frontiers in Pharmacology;2022-06-06